Evidence map›Paper›PMID 25561812›Full record

ArticleWorld journal of gastroenterology2014

Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.

Shao-Wei Xiong, Dong-Yun Zhang, Xian-Ming Liu, Zeng Liu, Fang-Ting Zhang

Open access · hybridAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shao-Wei XiongShao-Wei Xiong, Xian-Ming Liu, Zeng Liu, Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Dong-Yun ZhangShao-Wei Xiong, Xian-Ming Liu, Zeng Liu, Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Xian-Ming LiuShao-Wei Xiong, Xian-Ming Liu, Zeng Liu, Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Zeng LiuShao-Wei Xiong, Xian-Ming Liu, Zeng Liu, Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Fang-Ting ZhangShao-Wei Xiong, Xian-Ming Liu, Zeng Liu, Department of General Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.
Shenzhen Chronic Disease Prevention Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the effect of different Roux-en-Y gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.

methodsA retrospective analysis of the clinical data of 54 patients with gastric cancer and type 2 diabetes mellitus treated in the Department of General Surgery from January 2006 to June 2013 was conducted. The patients underwent gastrectomy using different Roux-en-Y gastric bypass procedures (traditional, n = 26; modified, n = 28). Fasting plasma glucose (FPG), two hour postprandial blood glucose (2 h PBG) and hemoglobin A1c (HbA1c) were analyzed before surgery (0 mo) and 1, 3 and 6 mo after surgery.

resultsFPG and 2 h PBG levels were significantly decreased 1 mo after surgery in the traditional Roux-en-Y gastric bypass group (FPG 7.5 ± 1.3 vs 10.7 ± 1.2, P < 0.05) (2 h PBG 10.2 ± 1.8 vs 13.8 ± 3.2, P < 0.05). FPG and 2 h PBG levels were significantly decreased after surgery in the modified Roux-en-Y gastric bypass group (FPG 6.9 ± 1.2 vs 10.5 ± 1.1, 6.5 ± 1.3 vs 10.5 ± 1.1, 6.4 ± 1.2 vs 10.5 ± 1.1, P < 0.05) (2 h PBG 9.9 ± 2.2 vs 14.1 ± 2.9, 9.2 ± 2.4 vs 14.1 ± 2.9, 8.9 ± 2.6 vs 14.1 ± 2.9, P < 0.05). Compared with the levels before surgery, HbA1c levels were significantly decreased 3 and 6 mo after surgery (7.2 ± 1.1 vs 10.5 ± 1.1, 5.5 ± 1.1 vs 10.5 ± 1.1, P < 0.05). Significant differences between the two groups regarding FPG, 2 h PBG and HbA1c concentration were observed 3 and 6 mo after surgery (FPG 10.1 ± 1.5 vs 6.5 ± 1.3, 10.3 ± 1.4 vs 6.4 ± 1.2, P < 0.05) (2 h PBG 13.1 ± 2.8 vs 9.2 ± 2.4, 13.6 ± 3.1 vs 8.9 ± 2.6, P < 0.05) (HbA1c 10.1 ± 1.4 vs 7.2 ± 1.1, 10.5 ± 1.3 vs 5.5 ± 1.1, P < 0.05).

conclusionModified Roux-en-Y gastric bypass can improve glucose metabolism in type 2 diabetic patients with gastric cancer.

Indexed as

AdultBiomarkersBlood GlucoseCarcinomaDiabetes Mellitus, Type 2FastingFemaleGastrectomyGastric BypassGlycated HemoglobinHumansMaleMiddle AgedPostprandial PeriodRetrospective StudiesStomach NeoplasmsBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanFasting plasma glucoseGastric cancerHemoglobin A1CRoux-en-Y gastric bypassType 2 diabetes mellitus

Identifiers

PMID25561812
PMCPMC4277982
OpenAlexW2322536592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.